Have a personal or library account? Click to login
Level of 25-Hydroxyvitamin D in Pediatric Arthritis Patients Cover

References

  1. Abudawood, M., Tabassum, H., Ansar, S., Almosa, K., Sobki, S., Ali, M. N., Aljohi, A. (2018). Assessment of gender-related differences in vitamin D levels and cardiovascular risk factors in Saudi patients with type 2 diabetes mellitus. Saudi J. Biol. Sci.,25 (1), 31–36.10.1016/j.sjbs.2017.04.001577508229379353
  2. Ahmadieh, H., Azar, S. T., Lakkis, N., Arabi, A. (2013). Hypovitaminosis d in patients with type 2 diabetes mellitus: A relation to disease control and complications. ISRN Endocronol., 2013, doi: 10.1155/2013/641098.10.1155/2013/64109824251044381975824251044
  3. AlSaleem, A., AlSaghier, A., Al-Mayouf, S. M. (2015). Vitamin D status in children with systemic lupus erythematosus and its association with clinical and laboratory parameters. Clin. Rheumatol.,34 (1), 81–84.10.1007/s10067-014-2811-z25367346
  4. Anonymous (2014). Vitamin D levels suboptimal for 1 in 10 US children. Reuters Health Information. 10 April 2014.
  5. Ashraf, A. P., Fisher, G., Alvarez, J., Dudenbostel, T., Calhoun, D. A., Szalai, A. J., Gower, B. A. (2012). Associations of C-reactive protein to indices of vascular health and the influence of serum 25 (OH) D status in healthy adults. J. Nutr. Metab.,2012, doi: 10.1155/2012/475975.10.1155/2012/475975345762823029606
  6. Atwa, M. A., Balata, M. G., Hussein, A. M., Abdelrahman, N. I., Elminshawy, H. H. (2013). Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Med., J.,34 (8), 806–813.
  7. Azizieh, F., Alyahya, K. O., Raghupathy, R. (2016). Association between levels of vitamin D and inflammatory markers in healthy women. J. Inflamm. Res.,9, 51–57.10.2147/JIR.S103298485430927175089
  8. Bani-issa, W., Eldeirawi, K., Harfil, S., Fakhry, R. (2017). Vitamin D deficiency and its determinants in adults: A sample from community-based settings in the United Arab Emirates. Int. J. Endocrinol.,2017, Article ID 3906306.10.1155/2017/3906306535296628352281
  9. Bellia, A., Garcovich, C., D’Adamo, M., Lombardo, M., Tesauro, M., Donadel, G., Sbraccia, P. (2013). Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern. Emerg. Med.,8 (1), 33–40.10.1007/s11739-011-0559-x21437585
  10. Bonakdar, Z. S., Jahanshahifar, L., Jahanshahifar, F., Gholamrezaei, A. (2011). Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus, 20 (11), 1155–1160.10.1177/096120331140570321680639
  11. Booth, D. R., Ding, N., Parnell, G. P., Shahijanian, F., Coulter, S., Schibeci, S. D., Atkins, A.R., Stewart, G.J., Evans, R.M., Downes, M., Liddle, C. (2016). Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases. Genes Immun.,17 (4), 213–219.2698678210.1038/gene.2016.12489538926986782
  12. Busse, J. A., Seelaboyina, K. N., Malonga, G., Setty, M. J., Moulton, T. (2013). Vitamin D level and its correlation with hemoglobin in pediatric sickle cell disease patients. Blood, 122, 4677.10.1182/blood.V122.21.4677.4677
  13. Cantorna, M. T. (2000). Vitamin D and autoimmunity: Is vitamin D status an environmental factor affecting autoimmune disease prevalence? (44485). Proc. Soc. Exper. Biol. Med.,223 (3), 230–233.10.1046/j.1525-1373.2000.22333.x10719834
  14. Cantorna, M. T., Zhu, Y., Froicu, M., Wittke, A. (2004). Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Amer. J. Clin. Nutr.,80 (6), 1717S–1720S.10.1093/ajcn/80.6.1717S
  15. Cashman, K. D., Dowling, K. G., Škrabáková, Z., Gonzalez-Gross, M., Valtueńa, J., De Henauw, S., Moreno, L., Damsgaard, C. T., Michaelsen, K. F., Mølgaard, C., Jorde, R., Grimnes, G., Moschonis, G., Mavrogianni, C., Manios, Y., Thamm, M., Mensink, G. B., Rabenberg, M., Busch, M. A., Cox, L., Meadows, S., Goldberg, G., Prentice, A., Dekker, J. M., Nijpels, G., Pilz, S., Swart, K. M., van Schoor, N. M., Lips, P., Eiriksdottir, G., Gudnason, V., Cotch, M. F., Koskinen, S., Lamberg-Allardt, C., Durazo-Arvizu, R. A., Sempos, C. T., Kiely, M. (2016). Vitamin D deficiency in Europe: pandemic. Amer. J. Clin. Nutr.,103 (4), 1033–1044.10.3945/ajcn.115.120873552785026864360
  16. Cheng, S., Massaro, J. M., Fox, C. S., Larson, M. G., Keyes, M. J., McCabe, E. L., Booth, S. L. (2010). Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes, 59 (1), 242–248.10.2337/db09-1011279792819833894
  17. Christakos, S., Dhawan, P., Liu, Y., Peng, X., Porta, A. (2003). New insights into the mechanisms of vitamin D action. J. Cell.Biochem.,88 (4), 695–705.10.1002/jcb.1042312577303
  18. Cieślińska, A., Kostyra, E., Chwała, B., Moszyñska-Dumara, M., Fiedorowicz. E., Teodorowicz, M., Savelkoul, H. F. J. (2017).Vitamin D receptor gene polymorphisms associated with childhood autism. Brain Sci., 7 (9), 115.10.3390/brainsci7090115561525628891930
  19. Çomak, E., Doğan, Ç. S., Uslu-Gökçeoğlu, A., Akbaş, H., Özdem, S., Koyun, M., Akman, S. (2014). Association between vitamin D deficiency and disease activity in juvenile idiopathic arthritis. Turkish J. Pediatr.,56 (6), 626–631.
  20. De Oliveira, C., Biddulph, J. P., Hirani, V., Schneider, I. J. C. (2017). Vita-min D and inflammatory markers: Cross-sectional analyses using data from the English Longitudinal Study of Ageing (ELSA). J. Nutr. Sci.,6, doi: 10.1017/jns.2016.37.10.1017/jns.2016.37546585828620476
  21. de Sousa Studart, S. A., Leite, A. C. R. M., Marinho, A. L. L. F., Pinto, A. C. M. D., Jśnior, C. N. R., de Melo Nunes, R., Rocha, F. A. C. (2015). Vitamin D levels in juvenile idiopathic arthritis from an equatorial region. Rheumatol. Int.,35 (10), 1717–1723.10.1007/s00296-015-3287-025991398
  22. de Souza, W. N., Norde, M. M., Oki, É., Rogero, M. M., Marchioni, D. M., Fisberg, R. M., Martini, L. A. (2016). Association between 25-hydroxyvitamin D and inflammatory biomarker levels in a cross-sectional population-based study, Sćo Paulo, Brazil. Nutr. Res.,36 (1), 1–8.10.1016/j.nutres.2015.10.006
  23. Drincic, A. T., Armas, L. A., Van Diest, E. E., Heaney, R. P. (2012). Volu-metric dilution rather than sequestration best explains the low vitamin D status of obesity. Obesity, 20 (7), 1444–1448.10.1038/oby.2011.40422262154
  24. Eleftheriadis, T., Antoniadi, G., Liakopoulos, V., Stefanidis, I., Galaktidou, G. (2012). Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemo-dialysis patients. Iran. J. Kidney Kidney Dis.,6 (2), 129–135.
  25. Elizondo-Montemayor, L., Castillo, E. C., Rodríguez-López, C., Villarreal-Calderón, J. R., Gómez-Carmona, M., Tenorio-Martínez, S., Nieblas, B., García-Rivas, G. (2017). Seasonal variation in vitamin D in association with age, inflammatory cytokines, anthropometric parameters, and lifestyle factors in older adults. Mediators Inflamm.,2017, doi: 10.1155/2017/5719461.10.1155/2017/5719461561876529104377
  26. Ernst, J. B., Tomaschitz, A., Grübler, M. R., Gaksch, M., Kienreich, K., Verheyen, N., Zittermann, A. (2016). Vitamin D supplementation and hemoglobin levels in hypertensive patients: A randomized controlled trial. Int. J. Endocrinol.,2016, article ID 6836402.10.1155/2016/6836402478195827006655
  27. Gharaibeh, M. A., Stoecker, B. J. (2009). Assessment of serum 25 (OH) D concentration in women of childbearing age and their preschool children in Northern Jordan during summer. Eur. J. Clin. Nutr.,63 (11), 1320–1326.10.1038/ejcn.2009.9919707220
  28. Hajjaj-Hassouni, N., Mawani, N., Allali, F., Rkain, H., Hassouni, K., Hmamouchi, I., Dougados, M. (2017). Evaluation of vitamin D status in rheumatoid arthritis and its association with disease activity across 15 countries: “The COMORA Study”. Int. J. Rheumatol.,2017, doi: 10.1155/2017/5491676.10.1155/2017/5491676547155328656048
  29. Ikeda, U., Wakita, D., Ohkuri, T., Chamoto, K., Kitamura, H., Iwakura, Y., Nishimura, T. (2010). 1į, 25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol. Lett.,134 (1), 7–16.10.1016/j.imlet.2010.07.00220655952
  30. Inanir, A., Özoran, K., Tutkak, H., Mermerci, B. (2004). The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-į concentrations in post-menopausal patients with osteoporosis. J. Int. Med. Res.,32 (6), 570–582.10.1177/14732300040320060215587751
  31. Jeng, L., Yamshchikov, A. V., Judd, S. E., Blumberg, H. M., Martin, G. S., Ziegler, T. R., Tangpricha, V. (2009). Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J. Transl. Med.,7 (1), 28.10.1186/1479-5876-7-28268474019389235
  32. Kumaratne, M., Early, G., Cisneros, J. (2017). Vitamin D deficiency and association with body mass index and lipid levels in Hispanic American adolescents. Global Pediatric Health,4, 2333794X17744141.10.1177/2333794X17744141572463229242817
  33. Lippi, G., Bonelli, P., Buonocore, R., Aloe, R. (2015). Birth season and vita-min D concentration in adulthood. Ann. Transl. Med., 3 (16), 231.
  34. Mangin, M., Sinha, R., Fincher, K. (2014). Inflammation and vitamin D: The infection connection. Inflamm. Res., 63 (10), 803–819.10.1007/s00011-014-0755-z416056725048990
  35. Michos, E. D., Streeten, E. A., Ryan, K. A., Rampersaud, E., Peyser, P. A., Bielak, L. F., Post, W. (2009). Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish. Calcif. Tiss. Int.,, 84 (3), 195–202.10.1007/s00223-008-9209-3290830219148561
  36. Mithal, A., Wahl, D. A., Bonjour, J. P., Burckhardt, P., Dawson-Hughes, B., Eisman, J. A., El-Hajj Fuleihan, G., Josse, R. G., Lips, P., Morales-Torres, J.; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group (2009). Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis Int.,20 (11), 1807–1820.10.1007/s00198-009-0954-619543765
  37. Mok, C. C., Birmingham, D. J., Ho, L. Y., Hebert, L. A., Song, H., Rovin, B. H. (2012). Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: A comparison with anti-dsDNA and anti-C1q. Lupus, 21 (1), 36–42.10.1177/096120331142209421993384
  38. Molla, A. M., Al Badawi, M., Hammoud, M. S., Molla, A. M., Shukkur, M., Thalib, L., Eliwa, M. S. (2005). Vitamin D status of mothers and their neonates in Kuwait. Pediatr. Int.,47 (6), 649–652.1635421810.1111/j.1442-200x.2005.02141.x16354218
  39. Mukane, M., Rasa, I., Mukans, M. (2016). First epidemiological study about vitamin D status and lifestyle factors in healthy young adults from Latvia: DLAT study, 2012. Osteoporos. Int., 27 (1).
  40. Myszka, M., Klinger, M. (2014). The immunomodulatory role of Vitamin D. Postepy higieny i medycyny doswiadczalnej, 68, 865–878.10.5604/17322693.111016824988607
  41. Nesby-O'Dell, S., Scanlon, K. S., Cogswell, M. E., Gillespie, C., Hollis, B. W., Looker, A. C., Allen, C., Doughertly, C., Gunter, E.W., Bowman, B. A. (2002). Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Amer J. Clin. Nutr.,76 (1), 187–192.10.1093/ajcn/76.1.18712081833
  42. Penna, G., Adorini, L. (2000). 1α, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol.,164 (5), 2405–2411.10.4049/jimmunol.164.5.240510679076
  43. Peterson, C. A., Heffernan, M. E. (2008). Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25 (OH) D concentrations in healthy women. J. Inflamm.,5 (1), 10.10.1186/1476-9255-5-10250397918652680
  44. Pike, J. W., Meyer, M. B. (2012). The vitamin D receptor: New paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D3. Rheum. Dis. Clin.,38 (1), 13–27.10.1016/j.rdc.2012.03.004444891922525840
  45. Popa, C., Netea, M. G., Van Riel, P. L., Van Der Meer, J. W., Stalenhoef, A. F. (2007). The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid. Res.,48 (4), 751–762.10.1194/jlr.R600021-JLR20017202130
  46. Pu, D., Luo, J., Wang, Y., Ju, B., Lv, X., Fan, P., He, L. (2018). Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level. Clin. Rheumatol.,37 (1), 179–184.2906346310.1007/s10067-017-3874-429063463
  47. Raman, M., Milestone, A. N., Walters, J. R., Hart, A. L., Ghosh, S. (2011). Vitamin D and gastrointestinal diseases: Inflammatory bowel disease and colorectal cancer. Ther. Adv. Gastroenterol.,4 (1), 49–62.10.1177/1756283X10377820303696121317994
  48. Ritterhouse, L. L., Crowe, S. R., Niewold, T. B., Kamen, D. L., Macwana, S. R., Roberts, V. C., James, J. A. (2011). Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann. Rheum. Dis.,70 (9), 1569–1574.10.1136/ard.2010.14849421586442314986521586442
  49. Rodriguez, A. J., Mousa, A., Ebeling, P. R., Scott, D., de Courten, B. (2018). Effects of vitamin D supplementation on inflammatory markers in heart failure: A systematic review and meta-analysis of randomized controlled trials. Sci. Rep.,8 (1), 1169.10.1038/s41598-018-19708-0
  50. Rovner, A. J., O’Brien, K. O. (2008). Hypovitaminosis D among healthy children in the United States: A review of the current evidence. Arch. Ped. Adolesc. Med.,162 (6), 513–519.10.1001/archpedi.162.6.51318524740
  51. Sadiya, A., Ahmed, S. M., Skaria, S., Abusnana, S. (2014). Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: A cross-sectional study. J. Diabetes Res.,2014, doi: 10.1155/2014/869307.10.1155/2014/869307421125325371907
  52. Schleithoff, S. S., Zittermann, A., Tenderich, G., Berthold, H. K., Stehle, P., Koerfer, R. (2006). Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Amer. J. Clin. Nutr.,83 (4), 754–759.10.1093/ajcn/83.4.75416600924
  53. Semjonova, J., Rasa, I. (2012). 25 (OH)D3 Status Among Adults in Latvia. In: 4th International Interdisciplinary Scientific Conference, Rīga, November 22–23, 2012. Society, Health, Welfare. Abstracts. Rīga: Rīgas Stradiņa Universitāte, pp. 95–95.
  54. Soliman, A. T., Eldabbagh, M., Elawwa, A., Saleem, W. (2012). Does vita-min D therapy affect hematological indices in adolescents with vitamin D deficiency? Indian J. Endocrinol. Metab., 16 (4), 659–660.10.4103/2230-8210.98038
  55. Staeva-Vieira, T. P., Freedman, L. P. (2002). 1, 25-dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol.,168 (3), 1181–1189.10.4049/jimmunol.168.3.118111801653
  56. Stagi, S., Cavalli, L., Bertini, F., Martino, M. D., Cerinic, M. M., Brandi, M. L., Falcini, F. (2014). Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: A cross-sectional study. Lupus, 23 (10), 1059–1065.10.1177/096120331453256424731961
  57. Szodoray, P., Tarr, T., Bazso, A., Poor, G., Szegedi, G., Kiss, E. (2011). The immunopathological role of vitamin D in patients with SLE: Data from a single centre registry in Hungary. Scand. J. Rheumatol.,40 (2), 122–126.10.3109/03009742.2010.5072202097738420977384
  58. Thudi, A., Yin, S. U., Wandstrat, A. E., Olsen, N. J., Li, Q. Z. (2008). Vita-min D levels and disease status in Texas patients with systemic lupus erythematosus. Amer. J. Med. Sci.,335 (2), 99–104.10.1097/MAJ.0b013e318134eeb618277116
  59. Tizaoui, K., Hamzaoui, K. (2015). Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case–control studies. Immunobiology, 220 (6), 807–816.10.1016/j.imbio.2014.12.01325577294
  60. Verdoia, M., Schaffer, A., Barbieri, L., Di Giovine, G., Marino, P., Suryapranata, H., De Luca, G.; Novara Atherosclerosis Study Group. (2015). Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease. Nutr. Metab. Cardiovasc. Dis.,25 (5), 464–470.10.1016/j.numecd.2015.01.00925791862
  61. Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., Holick, M. F. (2000). Decreased bioavailability of vitamin D in obesity. Amer. J. Clin. Nutr.,72 (3), 690–693.10.1093/ajcn/72.3.69010966885
  62. Yasmin, R., Williams, R. M., Xu, M., Noy, N. (2005). Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J. Biol. Chem.,280 (48), 40152–40160.10.1074/jbc.M50770820016204233
  63. Yildirim, I., Hur, E., Kokturk, F. (2013). Inflammatory markers: C-reactive protein, erythrocyte sedimentation rate, and leukocyte count in vitamin D deficient patients with and without chronic kidney disease. Int. J. Endocrinol.,2013, doi: 10.1155/2013/802165.2387853810.1155/2013/802165371059823878538
  64. Zostautiene, I., Jorde, R., Grimnes, G. (2016). No association between birth season and vitamin D concentration in adults in a North Norwegian population: The Tromso study. Ann. Transl. Med., 4 (1): 20, doi: 0.3978/j.issn.2305-5839.2015.12.54.
DOI: https://doi.org/10.2478/prolas-2019-0068 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 425 - 432
Submitted on: May 19, 2019
Accepted on: Jun 17, 2019
Published on: Nov 1, 2019
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2019 Marta Laizāne, Ieva Saulīte, Sandra Feierābende, Ingrīda Rumba-Rozenfelde, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.